13 Dec 2019 10:35
British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow
Source: Reuters - U.K. Health
A late-stage clinical trial has shown therapy combining Roche's...
Reuters - U.K. Health - 13 Dec 2019 08:05
(Reuters Health) - Adolescents who are active on social media may be...
Reuters - U.K. Health - 13 Dec 2019 22:10
Independent advisers to the U.S. Food and Drug Administration on...
Reuters - U.K. Health - 13 Dec 2019 20:51
Reuters - U.K. Health - 13 Dec 2019 22:05
Reuters - U.K. Health - 13 Dec 2019 13:12
Reuters - U.K. Health - 13 Dec 2019 20:44
Reuters - U.K. Health - 13 Dec 2019 21:13
Reuters - U.K. Health - 13 Dec 2019 17:11
Reuters - U.K. Health - 13 Dec 2019 16:58